OPKO Health (OPK)
1.18
-0.03 (2.48%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13D/A OPKO HEALTH, INC. Filed by: FROST PHILLIP MD ET AL
July 1, 2026 4:05 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Jun 18 Filed by: Lachman Prem A
June 22, 2026 5:38 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Jun 18 Filed by: MEDEL ROGER MD
June 22, 2026 5:37 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Jun 18 Filed by: PAGANELLI JOHN A
June 22, 2026 5:36 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Jun 18 Filed by: PFENNIGER RICHARD C JR
June 22, 2026 5:35 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Jun 18 Filed by: UPPALURI SUBBARAO V
June 22, 2026 5:33 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Jun 18 Filed by: Yu Alice Lin-Tsing
June 22, 2026 5:32 PM - SEC Filing
Form 8-K OPKO HEALTH, INC. For: Jun 18
June 18, 2026 4:07 PM - SEC Filing
ENTERA BIO shares preclinical data for two pipeline drugs at ENDO 2026
June 16, 2026 8:33 AM - StreetInsider
OPKO Biologics presents preclinical data for acromegaly drug candidate
June 15, 2026 8:00 AM - StreetInsider
Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026
June 15, 2026 8:00 AM - Globe NewsWire
Form DEFA14A OPKO HEALTH, INC.
May 15, 2026 4:44 PM - SEC Filing
OPKO's ModeX to present CAR-T cell generation data at gene therapy meeting
May 12, 2026 8:00 AM - StreetInsider
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
May 12, 2026 8:00 AM - Globe NewsWire
Form ARS OPKO HEALTH, INC. For: Dec 31
April 30, 2026 4:06 PM - SEC Filing
Form DEFA14A OPKO HEALTH, INC.
April 30, 2026 4:05 PM - SEC Filing
Form DEF 14A OPKO HEALTH, INC. For: Apr 30
April 30, 2026 4:03 PM - SEC Filing
OPKO Health receives 15% stake in Nicoya for China drug rights
April 30, 2026 8:31 AM - StreetInsider
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
April 30, 2026 8:30 AM - Globe NewsWire
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
April 30, 2026 8:00 AM - Globe NewsWire
Barrington Research Downgrades Opko Health (OPK) to Market Perform
April 29, 2026 7:38 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
April 29, 2026 7:22 AM - StreetInsider
OPKO Health (OPK) Misses Q1 EPS by 1c, provides guidance
April 28, 2026 4:10 PM - StreetInsider
Form 10-Q OPKO HEALTH, INC. For: Mar 31
April 28, 2026 4:10 PM - SEC Filing
Form 8-K OPKO HEALTH, INC. For: Apr 28
April 28, 2026 4:07 PM - SEC Filing
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
April 28, 2026 4:05 PM - Globe NewsWire
Full Article List
